Instrument: Illumina HiSeq 2500
Strategy: OTHER
Source: TRANSCRIPTOMIC
Selection: other
Layout: SINGLE
Construction protocol: Following treatment with indicated ribosome inhibitors, cells were lysed by triturating 10 times with 400 μL lysis buffer (20 mM Tris pH 7.56, 150 mM NaCl, 5 mM MgCl2, 1% Triton X-100 [Sigma], 1 mM DTT [Sigma], 8% glycerol, 100 μg/mL CHX, 12 units/mL Turbo DNase [Life Technologies]). Lysates were clarified by centrifuging at 20,000×g for 10 min at 4°C. Clarified lysate was flash frozen in liquid nitrogen. Clarified cell lysates were treated with RNase I (Life Technologies) to digest RNA not protected by ribosomes. High molecular weight species were isolated by centrifuging lysates through a 34% sucrose cushion at 200,000×g for 4 hours at 4°C. Pellets were resuspended in Trizol (Life Technologies) and the RNA fraction isolated. Contaminant rRNA was removed using the listed strategies. Total RNase I-treated RNA was size-separated by gel electrophoresis, and RNAs of size 28–34 nucleotides were purified. These ribosome protected fragments were cloned and sequenced via a single-end run on an Illumina HiSeq 2500 sequencer.